Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Study of Lumateperone in the Acute Treatment of Patients With Bipolar Mania

ClinicalTrials.gov ID: NCT06462586

Public ClinicalTrials.gov record NCT06462586. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 6, 2026, 2:48 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of Lumateperone in the Acute Treatment of Patients With Manic Episodes or Manic Episodes With Mixed Features Associated With Bipolar I Disorder (Bipolar Mania)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a multicenter, randomized, double-blind, placebo-controlled, study in the acute treatment of patients with a diagnosis of bipolar I disorder with manic episodes or manic episodes with mixed features (bipolar mania), with or without psychotic symptoms, according to criteria of the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM 5).

Study identification

NCT ID
NCT06462586
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Intra-Cellular Therapies, Inc.
Industry
Enrollment
354 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 18, 2024
Primary completion
Feb 23, 2026
Completion
Mar 4, 2026
Last update posted
Jul 23, 2026

2024 – 2026

United States locations

U.S. sites
23
U.S. states
8
U.S. cities
21
Facility City State ZIP Site status
Clinical Site Rogers Arkansas 72758
Clinical Site Bellflower California 90706
Clinical Site Culver City California 90230
Clinical Site Garden Grove California 92845
Clinical Site Lemon Grove California 91945
Clinical Site Montclair California 91763
Clinical Site Hallandale Florida 33009
Clinical Site Hialeah Florida 33016
Clinical Site Miami Florida 33184
Clinical Site Miami Gardens Florida 33056
Clinical Site Miami Lakes Florida 33016
Clinical Site Miami Springs Florida 33166
Clinical Site Orlando Florida 32807
Clinical Site Atlanta Georgia 30324
Clinical Site Atlanta Georgia 30338
Clinical Site Decatur Georgia 30030
Clinical Site Savannah Georgia 31405
Clinical Site Shreveport Louisiana 71101
Clinical Site Marlton New Jersey 08053
Clinical Site North Canton Ohio 44720
Clinical Site Austin Texas 78701
Clinical Site Austin Texas 78754
Clinical Site DeSoto Texas 75115

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 19 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06462586, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 23, 2026 · Synced Sep 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06462586 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →